PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Paradigm Ip Patents/ Trademarks, page-23

  1. 207 Posts.
    lightbulb Created with Sketch. 63
    @Gan_Gans, Thank you for the research findings. I noticed that the invention claim on the one you referenced excludes osteoarthritis as part of the coverage of the invention. Did you find others that cover specifically for osteoarthritis (in humans maybe)? I would be keen to find a reference to the list of patents they hold if you have it handy. Thanks.

    REF:
    The invention claimed is:
    1. A method for the treatment of bone marrow edema in a mammal not suffering from osteoarthritis, comprising administering intra-articularly or peri-articularly from about 1 mg/kg to about 2 mg/kg per dose of a polysulfated polysaccharide selected from the group consisting of pentosan polysulfate, the sodium salt of pentosan polysulfate (NaPPS), the magnesium salt of pentosan polysulfate (MgPPS), and the calcium salt of pentosan polysulfate (CaPPS) to a mammal in need of such treatment.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
-0.005(1.96%)
Mkt cap ! $87.44M
Open High Low Value Volume
25.5¢ 25.5¢ 25.0¢ $7.539K 29.82K

Buyers (Bids)

No. Vol. Price($)
2 4741 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 52986 15
View Market Depth
Last trade - 12.04pm 28/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.